IceCure Medical Ltd. (ICCM) stock
ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.83+0.07 (+9.21%)
Close on Nov 17, 2026Market cap $2.84MP/E 0.1Yield –
IceCure Medical r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was $7.43M, up 4.7% from the year before. The highest annual figure on record is $9.12M in fiscal 2022.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.43M | +4.7% |
| FY2024 | Dec 31, 2024 | $7.10M | -14.2% |
| FY2023 | Dec 31, 2023 | $8.27M | -9.3% |
| FY2022 | Dec 31, 2022 | $9.12M | +55.2% |
| FY2021 | Dec 31, 2021 | $5.88M | +54.3% |
| FY2020 | Dec 31, 2020 | $3.81M | +26.9% |
| FY2019 | Dec 31, 2019 | $3.00M | – |
See a number that looks wrong?